The molecular underpinnings of oligodendrocyte dysfunction in HD involve mHTT-mediated disruption of key transcriptional regulators such as MYRF and TCF7L2, dysregulated lipid and thiamine metabolism, altered BDNF signaling, and epigenetic dysregulation. The gene discussed is MYRF; the disease is Huntington disease.